Using Silica 12CH to Mitigate the Effects and Symptoms of Silicosis in Brazil
Status unconfirmed · Early Phase 1
Conditions studied: Silicosis
In brief
This clinical study aims to address a research and clinical treatment gap related to individuals with symptoms of Silicosis resulting from quartzite mining work. Silicosis represents a challenge in this specific population in Sao Thome das Letras, Minas Gerais. Silicosis is a severe disease and is considered incurable. Current conventional medicine only offers palliative care for those with Silicosis, highlighting the important and urgent need for research into complementary care approaches.
Key facts
- Study ID
- NCT06011785
- Run by
- HOHM Foundation
- People needed
- 100
- Starts
- 2024-03-01
- Expected to finish
- 2026-03-01
- Last updated by the study team
- 2024-02-28
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- To be eligible to participate, participants must meet the following criteria:
- must be at least 18 years old
- must have a clinical diagnosis of silicosis
- must be receiving conventional medical care and/or monitoring for their condition
You may not qualify if…
- ● Individuals under the age of 18
- individuals who are not receiving conventional medical care and/or monitoring for their condition
- individuals too infirm to receive regular monitoring as required for the study
- Interested participants without Silicosis
- Individuals with Tuberculosis
- Individuals defined as part of a vulnerable group
- legal or clinically incapable persons
- person in a state of temporary disability;
- of a member of indigenous community
Where it is running
- HOHM Foundation — Philadelphia, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.